Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

16S MiSeq sequencing data IFX response in adult IBD patients, biopsy

ABSTRACT: 16S MiSeq sequencing data IFX response in adult IBD patients, biopsy

PROVIDER: PRJEB87512 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR15002100.fastq.gz	Fastqsanger.gz
	ERR15002101.fastq.gz	Fastqsanger.gz
	ERR15002002.fastq.gz	Fastqsanger.gz
	ERR15002102.fastq.gz	Fastqsanger.gz
	ERR15001903.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 187

Similar Datasets

Human Intestinal biopsy tissue LC-MS

Project description:This is the first report of proteomic analysis for the identification of novel drug targets based on intestinal biopsy tissue, which is significant to hypotheses for mechanistic investigation that are responsible for non-response to IFX and the development of clinical new pharmaceutical drugs. All 12 UC patients were divided into responders to IFX (UCinfG), non-responders to IFX (UCinfL), severe UC (UCsevere) without IFX treatment history and mild UC (UCmild) without IFX treatment history.

2022-08-12 | PXD030121 | Pride

Biopsy expression profiling of an adult inflammatory bowel disease cohort

Project description:Inflammatory Bowel Disease (IBD) is a progressive disease of the gut and consists of two types, Crohn’s Disease (CD) and Ulcerative Colitis (UC). It is a complex disease involving genetic, microbial, and environmental factors. The incidence of IBD is steadily increasing and current therapeutic options are plateauing. Thus treatments are evolving to 1. deeper levels of remission from clinical to endoscopic and histologic normalization and 2. Embrace novel targets or drug combinations. We explored whole transcriptome data generated in biopsy specimens sampled from a large cohort of adult IBD and control subjects to provide 1. a granular, objective and sensitive molecular measures of disease activity in the gut and 2. Novel molecular mechanisms and biomarkers underlying IBD pathology.

2022-09-16 | GSE193677 | GEO

Bacterial and Fungal Profiles as Markers of Infliximab Drug Response in Inflammatory Bowel Disease

Project description:16S MiSeq sequencing data IFX response in adult IBD patients

| PRJEB51062 | ENA

Bacterial and Fungal Profiles as Markers of Infliximab Drug Response in Inflammatory Bowel Disease

Project description:ITS MiSeq sequencing data IFX response in adult IBD patients

| PRJEB50185 | ENA

RNAseq of pedriatic IBD and XIAP-deficient biopsy samples

Project description:RNAseq of pedriatic IBD and XIAP-deficient biopsy samples

| PRJNA759006 | ENA

RNAseq of pedriatic IBD and XIAP-deficient biopsy samples

Project description:Deficiency in the X-linked inhibitor of apoptosis protein (XIAP) is the cause for the X-linked lymphoproliferative syndrome 2 (XLP2). About one third of all patients suffers from severe and therapy refractory inflammatory bowel disease (IBD), but the exact pathogenesis remains undefined. We examined the differences in gene expression of pediatric XLP2 patients with IBD to healthy controls and pediatric IBD patients.

2021-09-20 | GSE183069 | GEO

16S IBD dataset

Project description:16S IBD dataset Raw sequence reads

| PRJNA552448 | ENA

Mucosal expression profiling in patients with inflammatory bowel disease before and after first infliximab treatment

Project description:We used microarrays to identify mucosal gene signatures predictive of response to infliximab (IFX) in patients with inflammatory bowel disease (IBD) and to gain more insight into the pathogenesis of IBD. Keywords: drug response and treatment effect

2009-11-03 | GSE16879 | GEO

Biopsy expression profiling of an adult inflammatory bowel disease cohort

Project description:Biopsy expression profiling of an adult inflammatory bowel disease cohort

| PRJNA797175 | ENA

Miseq-test

Project description:miseq-test

| PRJEB5483 | ENA